# 20/20 Biolabs, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/20-20-biolabs-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 14 |
| Claims under review | 1 |
| Evidence records | 7 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-15T04:47:17.989287+00:00 |
| Last reviewed | 2026-10-15T04:47:17.989287+00:00 |

## Identity

- Legal name: 20/20 Biolabs, Inc.
- Display name: 20/20 Biolabs, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-15T18:50:18.012819+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.847 |
| Directors | 5 |
| Committees | 0 |
| Governance events | 10 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- John G. Compton, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-06-23. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:5
- John W. Rollins: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:6
- Jonathan Cohen: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-06-23. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:7
- Michael A. Ross, M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:8
- Prasanth Reddy: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:9

## Executive leadership

- Alan B. Bergman: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:10
- Jiming Zhou, Ph.D.: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:11
- Jonathan Cohen: Chief Executive Officer, President and Director [CEO]. Status: current. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:12
- Michael Lebowitz, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:13
- Ron Baker: Chief Business Officer. Status: current. claim_id=alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:14

## Governance events

- DIRECTOR_APPOINTED: John G. Compton, Ph.D. seat on 20/20 Biolabs, Inc., effective 2026-06-23. Effective: 2026-06-23. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:qcuws81iqyre6
- DIRECTOR_APPOINTED: Jonathan Cohen seat on 20/20 Biolabs, Inc., effective 2026-06-23. Effective: 2026-06-23. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:lgnamc8mv440
- CFO_CHANGED: Alan B. Bergman executive of 20/20 Biolabs, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:1xkg0uck4uxba
- EXECUTIVE_APPOINTED: Jiming Zhou, Ph.D. executive of 20/20 Biolabs, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:1g7y9btoira6r
- CEO_CHANGED: Jonathan Cohen executive of 20/20 Biolabs, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:175w70ab62ae
- EXECUTIVE_APPOINTED: Michael Lebowitz, Ph.D. executive of 20/20 Biolabs, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:1r2zz8wz71x2
- EXECUTIVE_APPOINTED: Ron Baker executive of 20/20 Biolabs, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:qvr64fryay87
- DIRECTOR_APPOINTED: Prasanth Reddy seat on 20/20 Biolabs, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:m3kknarpjwm0
- DIRECTOR_APPOINTED: John W. Rollins seat on 20/20 Biolabs, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:14780bu6g6f6o
- DIRECTOR_APPOINTED: Michael A. Ross, M.D. seat on 20/20 Biolabs, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-15T04:47:17.989287+00:00. event_id=alpha:event:transition:1p9w6rleou76v

## Scoped resources

- `alpha://company/20-20-biolabs-inc` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record
- `alpha://company/20-20-biolabs-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=identity
- `alpha://company/20-20-biolabs-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=corporate-structure
- `alpha://company/20-20-biolabs-inc/board` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=board
- `alpha://company/20-20-biolabs-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=committees
- `alpha://company/20-20-biolabs-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=leadership
- `alpha://company/20-20-biolabs-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=ownership
- `alpha://company/20-20-biolabs-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=financials
- `alpha://company/20-20-biolabs-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=capital-structure
- `alpha://company/20-20-biolabs-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=compensation
- `alpha://company/20-20-biolabs-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=governance
- `alpha://company/20-20-biolabs-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=shareholder-governance
- `alpha://company/20-20-biolabs-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=audit
- `alpha://company/20-20-biolabs-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=legal
- `alpha://company/20-20-biolabs-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=risk
- `alpha://company/20-20-biolabs-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=cyber
- `alpha://company/20-20-biolabs-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=ai-governance
- `alpha://company/20-20-biolabs-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=agents
- `alpha://company/20-20-biolabs-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=ecosystem
- `alpha://company/20-20-biolabs-inc/events` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=events
- `alpha://company/20-20-biolabs-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=relationships
- `alpha://company/20-20-biolabs-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=assessments
- `alpha://company/20-20-biolabs-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- John G. Compton, Ph.D.: Director. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:5. Valid from: 2026-06-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:453b471029608c5383af0da0a320745884addc211ffc9b3afe3d6c172f6be351.
- John W. Rollins: Director. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:6. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:453b471029608c5383af0da0a320745884addc211ffc9b3afe3d6c172f6be351.
- Jonathan Cohen: Director. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:7. Valid from: 2026-06-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:453b471029608c5383af0da0a320745884addc211ffc9b3afe3d6c172f6be351.
- Michael A. Ross, M.D.: Director. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:8. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:453b471029608c5383af0da0a320745884addc211ffc9b3afe3d6c172f6be351.
- Prasanth Reddy: Director. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:453b471029608c5383af0da0a320745884addc211ffc9b3afe3d6c172f6be351.
- Alan B. Bergman: Chief Financial Officer. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:10. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:53918a7a256ae1b9f71146f1a48e1d64cf910a515ccb9500aaff1242c63c968e.
- Jiming Zhou, Ph.D.: Chief Operating Officer. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:11. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fb4391a03c43aa66452924fdaf87f07eb8484af54ecfce50583b17f7d14eff96.
- Jonathan Cohen: Chief Executive Officer, President and Director. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:12. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab7ac940288f12c245b928e5255814c6bed6151ebf786db5eb27434136d5e4d3.
- Michael Lebowitz, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:13. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b7f560573362ea28aa1aa4cfa6e9fabbba9b583db3616393fa7c4b6f2506ddc.
- Ron Baker: Chief Business Officer. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:leadership_role:14. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eecf89055407307d67019557a00354595923f1e7c30969771459ef022fbb1811.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- 20/20 Biolabs, Inc.. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e65b79077467b2c184e0b53e4f0eb0f04580c49f0a43354ec63d0a2202008252.

## Entity Status

- Public listing published. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e65b79077467b2c184e0b53e4f0eb0f04580c49f0a43354ec63d0a2202008252.

## Published Fact

- US. Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e65b79077467b2c184e0b53e4f0eb0f04580c49f0a43354ec63d0a2202008252.

## Security Listing

- AIDX (NASDAQ). Claim: alpha:claim:company:150c701a-76b2-4b41-8bb5-d3a4b5d2d8b4:security_listing:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e65b79077467b2c184e0b53e4f0eb0f04580c49f0a43354ec63d0a2202008252.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:e65b79077467b2c184e0b53e4f0eb0f04580c49f0a43354ec63d0a2202008252: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/20-20-biolabs-inc).
- alpha:projection-evidence:document:453b471029608c5383af0da0a320745884addc211ffc9b3afe3d6c172f6be351: [20/20 Biolabs, Inc. DEF 14A 2026-06-23](https://www.sec.gov/Archives/edgar/data/1139685/000121390026071172/ea0295686-def14a_2020bio.htm).
- alpha:projection-evidence:document:53918a7a256ae1b9f71146f1a48e1d64cf910a515ccb9500aaff1242c63c968e: [AIDX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1139685/000121390026037667/ea0283134-10k_2020bio.htm).
- alpha:projection-evidence:document:fb4391a03c43aa66452924fdaf87f07eb8484af54ecfce50583b17f7d14eff96: [AIDX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1139685/000121390026037667/ea0283134-10k_2020bio.htm).
- alpha:projection-evidence:document:ab7ac940288f12c245b928e5255814c6bed6151ebf786db5eb27434136d5e4d3: [AIDX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1139685/000121390026037667/ea0283134-10k_2020bio.htm).
- alpha:projection-evidence:document:7b7f560573362ea28aa1aa4cfa6e9fabbba9b583db3616393fa7c4b6f2506ddc: [AIDX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1139685/000121390026037667/ea0283134-10k_2020bio.htm).
- alpha:projection-evidence:document:eecf89055407307d67019557a00354595923f1e7c30969771459ef022fbb1811: [AIDX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1139685/000121390026037667/ea0283134-10k_2020bio.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/20-20-biolabs-inc)
- [Public Markdown](https://registry.alpha.ac/companies/20-20-biolabs-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/20-20-biolabs-inc?format=jsonld)
- MCP resource: `alpha://companies/20-20-biolabs-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-15T18:50:17.830584+00:00; recorded 2026-10-15T18:50:17.830584+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.